Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px
Organisation › Details

3a-Diagnostics GmbH

3a is a research-based biotechnology company located Southeast of Stuttgart, Germany, specializing in the development, production and marketing of point-of-care test systems. 3a has developed a pipeline of peptide-based biosensor screening tests for bacterial and viral infectious diseases which include stomatitis, periimplantitis, periodontitis, scarlet fever, and influenza. Positive detection of the causative pathogen results in enzymatic release of an extreme (but safe) bitter compound. 3a has also designed a scalable next generation microbial-enzyme screening tool for high-throughput identification of biosensor targets to facilitate rapid development of new tests. *


Period Start 2019-10-15 established (s-off
  Group XPhyto Therapeutics (Group)
  Predecessor University of Würzburg
Products Industry diagnostics (medical/biological)
  Industry 2 point-of-care diagnostic device
Person Person Jehle, Heinrich (3a-diagnostics 201910– Managing Director)
Region Region Frickenhausen
  Country Germany
  Street 17 Bettackerstr.
  City 72636 Frickenhausen
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: XPhyto Therapeutics Corporation. (7/20/21). "Press Release: XPhyto Signs Transformative Acquisition Agreement with 3a-Diagnostics, to Enter Hi-tech Biosensor Market and Expand Its Diagnostic Product Portfolio". Vancouver, BC & Frankfurt.
Record changed: 2021-08-10


Picture [iito] Plain Stupid Simple 650x80px

More documents for XPhyto Therapeutics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC E Hand 650x300px

» top